e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): August 13, 2007
THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or other
jurisdiction of
incorporation or
organization)
     
1-07151   31-0595760
(Commission File
Number)
  (I.R.S. Employer
Identification No.)
1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)
(510) 271-7000
(Registrant’s telephone number, including area code)
 (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)
o   Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 1.01 Entry into a Material Definitive Agreement
Item 9.01 Financial Statements and Exhibits
SIGNATURES
INDEX TO EXHIBITS
EXHIBIT 99.1


Table of Contents

Item 1.01 Entry into a Material Definitive Agreement
     On August 13, 2007, The Clorox Company (“Clorox”) issued a press release announcing that it has entered into an accelerated share repurchase agreement (ASR) with Citibank, N.A. and JP Morgan Chase Bank, National Association. Through the accelerated share repurchase agreement, Clorox has repurchased $750 million in shares under its previously board-authorized $750 million stock repurchase program at an initial repurchase price of $59.59 per share, subject to adjustment. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
     (c) Exhibits
     
Exhibit   Description
99.1
  Press Release dated August 13, 2007 of The Clorox Company

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  THE CLOROX COMPANY
 
 
Date: August 13, 2007  By:   /s/ Laura Stein    
    Senior Vice President —   
    General Counsel   
 

 


Table of Contents

THE CLOROX COMPANY
FORM 8-K
INDEX TO EXHIBITS
           
 
  Exhibit     Description  
 
99.1
    Press Release dated August 13, 2007 of The Clorox Company